**Elon Musk Dismisses NYT Drug Allegations Amid Departure from Government Efficiency Post**

Elon Musk responded dismissively to a New York Times report alleging his drug use during his involvement with the Trump campaign during a press conference on Friday. This event marked the end of Musk's tenure with the Department of Government Efficiency (DOGE).

Earlier this week, Musk announced his resignation from the administration, closing a chapter characterized by his aggressive cost-cutting measures throughout the federal government.

When questioned about the report, Musk condemned The New York Times for their "lies about the Russiagate hoax" and urged to "move on."

President Trump, in his introductory remarks at the press conference, insisted that Musk is "really not leaving," suggesting he would maintain a recurring presence.

In a bold initiative, Musk and DOGE aimed to reduce federal spending by $2 trillion. A notable moment occurred in February when Musk joined Trump in the Oval Office to defend the budget cuts, stating that Americans had voted for significant government reforms.

Despite Musk's exit, several legal challenges have emerged in response to the drastic cuts instigated by DOGE, which created chaos among federal employees. Judges nationwide may continue to dismantle key aspects of Musk's controversial campaign.

In his final days as a "special government employee," Musk shifted his focus to his private ventures in space exploration, automotive innovation, and robotics. He confirmed his departure from the Trump administration but remains one of the president's most influential external advisors.

Musk acknowledged that the budget-cutting objectives under DOGE fell short of his expectations. Initially slated to conclude on July 4, 2026, Musk now suggests that DOGE could continue its mission to oversee federal spending reductions until the end of 2028.